Medical News

Neoadjuvant Chemoradiotherapy for Patients with Unresectable...
BMC Cancer

NACRT followed by surgery was feasible and safe for selected patients with LACC, and can be used as a conversion...

22 Feb 2021

Bevacizumab for Radiation Necrosis Following Radiotherapy of...
BMC Cancer

Bevacizumab presents a promising treatment strategy for patients with RN and brain metastatic disease....

17 Feb 2021

Pyrotinib plus Capecitabine Versus Lapatinib Plus Capecitabi...
Lancet Oncol

Pyrotinib plus capecitabine significantly improved progression-free survival compared with that for lapatinib plus...

15 Feb 2021

Accuracy of Morphologic Change Measurements by Ultrasound in...
Breast Cancer

TNBC and HER2 + ve BC showed different morphologic features of residual disease. Echogenicity and tumor size after...

12 Feb 2021

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Lymphoma

This publication covers the key trials on rituximab in the treatment of various lymphomas.

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Lung Cancer

This slide set provides information on types of lung cancer,epidemiology, pathophysiology, risk factors/causes, clinical features, diagnosis,...

 
Email this page

Key Trials

Efficacy and Safety of Lenvatinib in Patients with Iodine 131-refractory Thyroid Cancer

The present study evaluated progression-free survival among patients with iodine-131–refractory thyroid cancer who received lenvatinib as compared...

Oncological and Functional Outcomes with High-Intensity Focused Ultrasound in the Treatment of Prostate Cancer

Partial-gland high-intensity focused ultrasound (HIFU) was safer than whole-gland HIFU, and they had similar oncological outcomes. More prospective...

Lapatinib plus Capecitabine versus Capecitabine Alone in Women with Progressive HER2-positive in Locally Advanced or Metastatic Breast Cancer

The present study compared lapatinib plus capecitabine with capecitabine alone in women with progressive, HER2-positive, locally advanced or...

Clinical Efficacy of Lapatinib Combined with Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast Cancer

This trial compared the combination of letrozole plus lapatinib with letrozole plus placebo as first-line treatment of patients with HR-positive MBC...

Patient Education

All You Wanted to Know About Thyroid Cancer

Thyroid cancer is relatively uncommon compared to other cancers. This input describes the risk factors, symptoms, diagnosis and over all treatment fo...

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer giv...

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
44% (4 votes)
Tegafur uracil
0% (0 votes)
5-FU
56% (5 votes)
Total votes: 9